Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797407 · ClinicalTrials.gov registry record · NA
Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00797407 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 12 participants.
The verdict
NCT00797407, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine of creatine will prevent or treat the muscle toxicity side effect of statin drug therapy, whose symptoms are aching, cramping, and weakness. This is tested in patients who have had this side effect from 3 different statin drugs.
Interventions
- DIETARY_SUPPLEMENT Creatine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-08 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00797407
The ClinicalTrials.gov registry entry for NCT00797407 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Creatine is the first listed.
NCT00797407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00797407 about?
NCT00797407 is a clinical study titled "Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs". The purpose of this study is to determine of creatine will prevent or treat the muscle toxicity side effect of statin drug therapy, whose symptoms are aching, cramping, and weakness. This is tested in patients who have had this side effect from 3 different statin drugs.
What is the current status of trial NCT00797407?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2006-08. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00797407?
The interventions under investigation include: Creatine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00797407?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.